Trial Outcomes & Findings for Mindful Minds: Mindfulness-Based Neurofeedback for Underrepresented College Students (NCT NCT06784934)
NCT ID: NCT06784934
Last Updated: 2026-08-04
Results Overview
Trier Social Stress Test will be utilized to induce performance anxiety through a mock job interview and mental arithmetic task conducted in front of a non-responsive committee at baseline and the final session (after 4 weeks). This test uses a standardized protocol that not only facilitates a more robust evaluation of our intervention but also elevates the ecological validity of the study by assessing its effects in a real-life scenario. The social stress test not only facilitates a more robust evaluation of our intervention but also elevates the ecological validity of the study by assessing its effects in a real-life scenario.
COMPLETED
NA
39 participants
Final session at 4 weeks
2026-08-04
Participant Flow
Participant recruitment occurred from January 6, 2025, through March 25, 2025. Multiple recruitment strategies were utilized to reach potential participants. These included the distribution of IRB-approved flyers across campus and community locations, targeted social media posts, and in-class announcements. These combined methods were used to maximize visibility and engagement with eligible participants throughout the recruitment period.
A total of 59 individuals expressed interest in the study. Of these, 21 were excluded prior to assignment: 5 did not meet inclusion criteria, 14 declined to participate, and 2 were excluded for other reasons. The remaining eligible participants were assigned to study groups.
Participant milestones
| Measure |
Mindfulness Neurofeedback
For the experimental group, participants will engage in a mindfulness-based neurofeedback training protocol designed to enhance academic performance and reduce performance anxiety. The intervention involves the use of NeuroSky and BrainTrain technology to provide real-time feedback on brain activity, helping participants develop better self-regulation skills. The training incorporates guided mindfulness exercises focused on promoting relaxation and sustained attention.
After the training with the researcher, the experimental group participants will go home and practice independently (10 -15 minutes of mindfulness-based neurofeedback training once daily) with weekly 10-minute virtual check-ins for 4 weeks. Participants will also be asked to record 5 minutes of heart rate variability (HRV) data using the OptimalHRV device twice a day to measure their HRV. At the end of the study, participants will return to the lab for one final mindfulness-meditation session.
|
Business as Usual
The control group participants will not engage in mindfulness-based neurofeedback training. Participants in the control group will continue their daily routines without meditation for 4 weeks. Heart rate variability (HRV) will be monitored using the OptimalHRV device to monitor HRV, but no intervention will be provided. Weekly 10-minute virtual check-ins with the research team will ensure compliance, address questions, and maintain engagement. Data collected from the OptimalHRV device will provide a baseline for comparison, helping to evaluate the effectiveness of the neurofeedback intervention in the experimental group.
|
|---|---|---|
|
Overall Study
STARTED
|
19
|
19
|
|
Overall Study
COMPLETED
|
18
|
16
|
|
Overall Study
NOT COMPLETED
|
1
|
3
|
Reasons for withdrawal
| Measure |
Mindfulness Neurofeedback
For the experimental group, participants will engage in a mindfulness-based neurofeedback training protocol designed to enhance academic performance and reduce performance anxiety. The intervention involves the use of NeuroSky and BrainTrain technology to provide real-time feedback on brain activity, helping participants develop better self-regulation skills. The training incorporates guided mindfulness exercises focused on promoting relaxation and sustained attention.
After the training with the researcher, the experimental group participants will go home and practice independently (10 -15 minutes of mindfulness-based neurofeedback training once daily) with weekly 10-minute virtual check-ins for 4 weeks. Participants will also be asked to record 5 minutes of heart rate variability (HRV) data using the OptimalHRV device twice a day to measure their HRV. At the end of the study, participants will return to the lab for one final mindfulness-meditation session.
|
Business as Usual
The control group participants will not engage in mindfulness-based neurofeedback training. Participants in the control group will continue their daily routines without meditation for 4 weeks. Heart rate variability (HRV) will be monitored using the OptimalHRV device to monitor HRV, but no intervention will be provided. Weekly 10-minute virtual check-ins with the research team will ensure compliance, address questions, and maintain engagement. Data collected from the OptimalHRV device will provide a baseline for comparison, helping to evaluate the effectiveness of the neurofeedback intervention in the experimental group.
|
|---|---|---|
|
Overall Study
Lost to Follow-up
|
1
|
2
|
|
Overall Study
Withdrawal by Subject
|
0
|
1
|
Baseline Characteristics
Analysis includes all participants with baseline PHQ-9 data; no exclusions.
Baseline characteristics by cohort
| Measure |
Mindfulness Neurofeedback
n=19 Participants
For the experimental group, participants will engage in a mindfulness-based neurofeedback training protocol designed to enhance academic performance and reduce performance anxiety. The intervention involves the use of NeuroSky and BrainTrain technology to provide real-time feedback on brain activity, helping participants develop better self-regulation skills. The training incorporates guided mindfulness exercises focused on promoting relaxation and sustained attention.
After the training with the researcher, the experimental group participants will go home and practice independently (10 -15 minutes of mindfulness-based neurofeedback training once daily) with weekly 10-minute virtual check-ins for 4 weeks. Participants will also be asked to record 5 minutes of heart rate variability (HRV) data using the OptimalHRV device twice a day to measure their HRV. At the end of the study, participants will return to the lab for one final mindfulness-meditation session.
|
Business as Usual
n=19 Participants
The control group participants will not engage in mindfulness-based neurofeedback training. Participants in the control group will continue their daily routines without meditation for 4 weeks. Heart rate variability (HRV) will be monitored using the OptimalHRV device to monitor HRV, but no intervention will be provided. Weekly 10-minute virtual check-ins with the research team will ensure compliance, address questions, and maintain engagement. Data collected from the OptimalHRV device will provide a baseline for comparison, helping to evaluate the effectiveness of the neurofeedback intervention in the experimental group.
|
Total
n=38 Participants
Total of all reporting groups
|
|---|---|---|---|
|
Age, Continuous
|
21.88 years
STANDARD_DEVIATION 2.39 • n=20 Participants
|
22.25 years
STANDARD_DEVIATION 2.84 • n=20 Participants
|
22.06 years
STANDARD_DEVIATION 2.58 • n=40 Participants
|
|
Sex: Female, Male
Female
|
13 Participants
n=20 Participants
|
16 Participants
n=20 Participants
|
29 Participants
n=40 Participants
|
|
Sex: Female, Male
Male
|
6 Participants
n=20 Participants
|
3 Participants
n=20 Participants
|
9 Participants
n=40 Participants
|
|
Race (NIH/OMB)
American Indian or Alaska Native
|
0 Participants
n=20 Participants
|
0 Participants
n=20 Participants
|
0 Participants
n=40 Participants
|
|
Race (NIH/OMB)
Asian
|
0 Participants
n=20 Participants
|
0 Participants
n=20 Participants
|
0 Participants
n=40 Participants
|
|
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
|
0 Participants
n=20 Participants
|
0 Participants
n=20 Participants
|
0 Participants
n=40 Participants
|
|
Race (NIH/OMB)
Black or African American
|
5 Participants
n=20 Participants
|
5 Participants
n=20 Participants
|
10 Participants
n=40 Participants
|
|
Race (NIH/OMB)
White
|
11 Participants
n=20 Participants
|
13 Participants
n=20 Participants
|
24 Participants
n=40 Participants
|
|
Race (NIH/OMB)
More than one race
|
0 Participants
n=20 Participants
|
0 Participants
n=20 Participants
|
0 Participants
n=40 Participants
|
|
Race (NIH/OMB)
Unknown or Not Reported
|
3 Participants
n=20 Participants
|
1 Participants
n=20 Participants
|
4 Participants
n=40 Participants
|
|
Ethnicity (NIH/OMB)
Hispanic or Latino
|
15 Participants
n=20 Participants
|
12 Participants
n=20 Participants
|
27 Participants
n=40 Participants
|
|
Ethnicity (NIH/OMB)
Not Hispanic or Latino
|
4 Participants
n=20 Participants
|
7 Participants
n=20 Participants
|
11 Participants
n=40 Participants
|
|
Ethnicity (NIH/OMB)
Unknown or Not Reported
|
0 Participants
n=20 Participants
|
0 Participants
n=20 Participants
|
0 Participants
n=40 Participants
|
|
Patient Health Questionnaire-9 (PHQ-9)
|
5.26 scores on a scale
STANDARD_DEVIATION 4.66 • n=20 Participants • Analysis includes all participants with baseline PHQ-9 data; no exclusions.
|
5.42 scores on a scale
STANDARD_DEVIATION 3.39 • n=20 Participants • Analysis includes all participants with baseline PHQ-9 data; no exclusions.
|
5.34 scores on a scale
STANDARD_DEVIATION 4.04 • n=40 Participants • Analysis includes all participants with baseline PHQ-9 data; no exclusions.
|
|
Beck Anxiety Inventory
|
31.63 scores on a scale
STANDARD_DEVIATION 8.36 • n=20 Participants • Analysis includes all participants with baseline PHQ-9 data; no exclusions.
|
35.16 scores on a scale
STANDARD_DEVIATION 12.20 • n=20 Participants • Analysis includes all participants with baseline PHQ-9 data; no exclusions.
|
33.39 scores on a scale
STANDARD_DEVIATION 10.48 • n=40 Participants • Analysis includes all participants with baseline PHQ-9 data; no exclusions.
|
|
Academic Anxiety Scale
|
17.58 scores on a scale
STANDARD_DEVIATION 5.78 • n=20 Participants • Analysis includes all participants with baseline PHQ-9 data; no exclusions.
|
20.16 scores on a scale
STANDARD_DEVIATION 4.74 • n=20 Participants • Analysis includes all participants with baseline PHQ-9 data; no exclusions.
|
18.87 scores on a scale
STANDARD_DEVIATION 5.42 • n=40 Participants • Analysis includes all participants with baseline PHQ-9 data; no exclusions.
|
|
Total Correct Responses on the Verbal Mental Arithmetic Task
|
7.0 Responses
STANDARD_DEVIATION 5.54 • n=20 Participants
|
7.63 Responses
STANDARD_DEVIATION 7.37 • n=20 Participants
|
7.32 Responses
STANDARD_DEVIATION 6.44 • n=40 Participants
|
PRIMARY outcome
Timeframe: Final session at 4 weeksPopulation: Participants were included if they completed the study and had initial and final verbal mental arithmetic task data. One mindfulness neurofeedback participant and three BAU participants were excluded because they discontinued the intervention before the final session.
Trier Social Stress Test will be utilized to induce performance anxiety through a mock job interview and mental arithmetic task conducted in front of a non-responsive committee at baseline and the final session (after 4 weeks). This test uses a standardized protocol that not only facilitates a more robust evaluation of our intervention but also elevates the ecological validity of the study by assessing its effects in a real-life scenario. The social stress test not only facilitates a more robust evaluation of our intervention but also elevates the ecological validity of the study by assessing its effects in a real-life scenario.
Outcome measures
| Measure |
Mindfulness Neurofeedback
n=18 Participants
For the experimental group, participants will engage in a mindfulness-based neurofeedback training protocol designed to enhance academic performance and reduce performance anxiety. The intervention involves the use of NeuroSky and BrainTrain technology to provide real-time feedback on brain activity, helping participants develop better self-regulation skills. The training incorporates guided mindfulness exercises focused on promoting relaxation and sustained attention.
After the training with the researcher, the experimental group participants will go home and practice independently (10 -15 minutes of mindfulness-based neurofeedback training once daily) with weekly 10-minute virtual check-ins for 4 weeks. Participants will also be asked to record 5 minutes of heart rate variability (HRV) data using the OptimalHRV device twice a day to measure their HRV. At the end of the study, participants will return to the lab for one final mindfulness-meditation session.
|
Business as Usual
n=16 Participants
The control group participants will not engage in mindfulness-based neurofeedback training. Participants in the control group will continue their daily routines without meditation for 4 weeks. Heart rate variability (HRV) will be monitored using the OptimalHRV device to monitor HRV, but no intervention will be provided. Weekly 10-minute virtual check-ins with the research team will ensure compliance, address questions, and maintain engagement. Data collected from the OptimalHRV device will provide a baseline for comparison, helping to evaluate the effectiveness of the neurofeedback intervention in the experimental group.
|
|---|---|---|
|
Total Correct Responses on the Verbal Mental Arithmetic Task - Final Session
|
6.29 Responses
Standard Deviation 6.15
|
6.94 Responses
Standard Deviation 4.06
|
PRIMARY outcome
Timeframe: Final session at 4 weeksPopulation: Baseline analyses included all participants, while outcome analyses included only those with complete follow-up data.
The Academic Anxiety Scale (AAS) will be used to examine performance anxiety at baseline and final session (after 4 weeks). This 11-item questionnaire uses a 4-point Likert Scale (1 = not at all typical of me to 4 = very typical of me) and measures broader aspects of academic-based anxiety beyond cognitive factors. The AAS includes items designed to assess apprehension and anxiety in academic settings, with high reliability (split-half Guttman reliability of 0.91 and Cronbach's Alpha of 0.94).
Outcome measures
| Measure |
Mindfulness Neurofeedback
n=18 Participants
For the experimental group, participants will engage in a mindfulness-based neurofeedback training protocol designed to enhance academic performance and reduce performance anxiety. The intervention involves the use of NeuroSky and BrainTrain technology to provide real-time feedback on brain activity, helping participants develop better self-regulation skills. The training incorporates guided mindfulness exercises focused on promoting relaxation and sustained attention.
After the training with the researcher, the experimental group participants will go home and practice independently (10 -15 minutes of mindfulness-based neurofeedback training once daily) with weekly 10-minute virtual check-ins for 4 weeks. Participants will also be asked to record 5 minutes of heart rate variability (HRV) data using the OptimalHRV device twice a day to measure their HRV. At the end of the study, participants will return to the lab for one final mindfulness-meditation session.
|
Business as Usual
n=16 Participants
The control group participants will not engage in mindfulness-based neurofeedback training. Participants in the control group will continue their daily routines without meditation for 4 weeks. Heart rate variability (HRV) will be monitored using the OptimalHRV device to monitor HRV, but no intervention will be provided. Weekly 10-minute virtual check-ins with the research team will ensure compliance, address questions, and maintain engagement. Data collected from the OptimalHRV device will provide a baseline for comparison, helping to evaluate the effectiveness of the neurofeedback intervention in the experimental group.
|
|---|---|---|
|
Academic Anxiety at Final Session
|
18.94 score
Standard Deviation 6.06
|
19.00 score
Standard Deviation 4.83
|
PRIMARY outcome
Timeframe: From enrollment to the end of treatment at 4 weeksPopulation: Participants with at least one completed weekly check-in response for the weekly experience question.
Semi-structured interviews will be conducted during the weekly check-ins to further our understanding of the intervention's acceptability utilizing qualitative techniques such as thematic analysis.
Outcome measures
| Measure |
Mindfulness Neurofeedback
n=16 Participants
For the experimental group, participants will engage in a mindfulness-based neurofeedback training protocol designed to enhance academic performance and reduce performance anxiety. The intervention involves the use of NeuroSky and BrainTrain technology to provide real-time feedback on brain activity, helping participants develop better self-regulation skills. The training incorporates guided mindfulness exercises focused on promoting relaxation and sustained attention.
After the training with the researcher, the experimental group participants will go home and practice independently (10 -15 minutes of mindfulness-based neurofeedback training once daily) with weekly 10-minute virtual check-ins for 4 weeks. Participants will also be asked to record 5 minutes of heart rate variability (HRV) data using the OptimalHRV device twice a day to measure their HRV. At the end of the study, participants will return to the lab for one final mindfulness-meditation session.
|
Business as Usual
n=17 Participants
The control group participants will not engage in mindfulness-based neurofeedback training. Participants in the control group will continue their daily routines without meditation for 4 weeks. Heart rate variability (HRV) will be monitored using the OptimalHRV device to monitor HRV, but no intervention will be provided. Weekly 10-minute virtual check-ins with the research team will ensure compliance, address questions, and maintain engagement. Data collected from the OptimalHRV device will provide a baseline for comparison, helping to evaluate the effectiveness of the neurofeedback intervention in the experimental group.
|
|---|---|---|
|
Number of Participants Reporting Weekly Experience Themes During the Intervention
Reported a positive or acceptable overall experience
|
15 Participants
|
17 Participants
|
|
Number of Participants Reporting Weekly Experience Themes During the Intervention
Reported a technology/device challenge
|
8 Participants
|
8 Participants
|
|
Number of Participants Reporting Weekly Experience Themes During the Intervention
Reported adherence, time, or routine barriers
|
8 Participants
|
9 Participants
|
|
Number of Participants Reporting Weekly Experience Themes During the Intervention
Reported stress, illness, or life events affecting experience
|
9 Participants
|
8 Participants
|
|
Number of Participants Reporting Weekly Experience Themes During the Intervention
Reported perceived benefits such as relaxation, focus, or self-regulation
|
4 Participants
|
7 Participants
|
PRIMARY outcome
Timeframe: Final session at 4 weeksPopulation: Baseline analyses included all participants, while outcome analyses included only those with complete follow-up data.
The Beck Anxiety Inventory (BAI) measured generalized anxiety at baseline and final session (after 4 weeks) using a 21-item Likert scale (0 to 3) to assess how distressing anxiety symptoms have been over the past week. Scores range from 0 to 63, with levels categorized as minimal (0-7), mild (8-15), moderate (16-25), and severe (30-63). The BAI has been widely used among racially diverse groups. The investigators hypothesize that BAI scores will vary significantly from pre- to post-intervention.
Outcome measures
| Measure |
Mindfulness Neurofeedback
n=18 Participants
For the experimental group, participants will engage in a mindfulness-based neurofeedback training protocol designed to enhance academic performance and reduce performance anxiety. The intervention involves the use of NeuroSky and BrainTrain technology to provide real-time feedback on brain activity, helping participants develop better self-regulation skills. The training incorporates guided mindfulness exercises focused on promoting relaxation and sustained attention.
After the training with the researcher, the experimental group participants will go home and practice independently (10 -15 minutes of mindfulness-based neurofeedback training once daily) with weekly 10-minute virtual check-ins for 4 weeks. Participants will also be asked to record 5 minutes of heart rate variability (HRV) data using the OptimalHRV device twice a day to measure their HRV. At the end of the study, participants will return to the lab for one final mindfulness-meditation session.
|
Business as Usual
n=16 Participants
The control group participants will not engage in mindfulness-based neurofeedback training. Participants in the control group will continue their daily routines without meditation for 4 weeks. Heart rate variability (HRV) will be monitored using the OptimalHRV device to monitor HRV, but no intervention will be provided. Weekly 10-minute virtual check-ins with the research team will ensure compliance, address questions, and maintain engagement. Data collected from the OptimalHRV device will provide a baseline for comparison, helping to evaluate the effectiveness of the neurofeedback intervention in the experimental group.
|
|---|---|---|
|
Academic Anxiety With Beck Anxiety Inventory at Final Session
|
32.53 score
Standard Deviation 11.09
|
33.06 score
Standard Deviation 7.05
|
PRIMARY outcome
Timeframe: From enrollment to the end of treatment at 4 weeksPopulation: Participants with at least one completed weekly check-in response for the technology issue item.
Semi-structured interviews will be conducted during the weekly check-ins to further our understanding of the intervention's feasibility utilizing qualitative techniques such as thematic analysis.
Outcome measures
| Measure |
Mindfulness Neurofeedback
n=16 Participants
For the experimental group, participants will engage in a mindfulness-based neurofeedback training protocol designed to enhance academic performance and reduce performance anxiety. The intervention involves the use of NeuroSky and BrainTrain technology to provide real-time feedback on brain activity, helping participants develop better self-regulation skills. The training incorporates guided mindfulness exercises focused on promoting relaxation and sustained attention.
After the training with the researcher, the experimental group participants will go home and practice independently (10 -15 minutes of mindfulness-based neurofeedback training once daily) with weekly 10-minute virtual check-ins for 4 weeks. Participants will also be asked to record 5 minutes of heart rate variability (HRV) data using the OptimalHRV device twice a day to measure their HRV. At the end of the study, participants will return to the lab for one final mindfulness-meditation session.
|
Business as Usual
n=17 Participants
The control group participants will not engage in mindfulness-based neurofeedback training. Participants in the control group will continue their daily routines without meditation for 4 weeks. Heart rate variability (HRV) will be monitored using the OptimalHRV device to monitor HRV, but no intervention will be provided. Weekly 10-minute virtual check-ins with the research team will ensure compliance, address questions, and maintain engagement. Data collected from the OptimalHRV device will provide a baseline for comparison, helping to evaluate the effectiveness of the neurofeedback intervention in the experimental group.
|
|---|---|---|
|
Number of Participants Reporting Technology-Related Feasibility Issues During Weekly Check-Ins
Reported at least one technology issue
|
6 Participants
|
6 Participants
|
|
Number of Participants Reporting Technology-Related Feasibility Issues During Weekly Check-Ins
Reported no technology issues
|
10 Participants
|
11 Participants
|
|
Number of Participants Reporting Technology-Related Feasibility Issues During Weekly Check-Ins
Had all reported technology issues resolved
|
3 Participants
|
3 Participants
|
|
Number of Participants Reporting Technology-Related Feasibility Issues During Weekly Check-Ins
Had at least one unresolved technology issue
|
3 Participants
|
3 Participants
|
|
Number of Participants Reporting Technology-Related Feasibility Issues During Weekly Check-Ins
Reported concerns about the technology
|
0 Participants
|
0 Participants
|
SECONDARY outcome
Timeframe: From enrollment to the end of treatment at 4 weeksThe Integrated Visual and Auditory Continuous Performance Test (IVA-2) will be used to assess attention as a secondary outcome. This computerized test measures both visual and auditory attention, providing an overall score of attentional functioning and response control. It evaluates sustained attention, impulsivity, and processing speed through a series of tasks requiring quick and accurate responses.The scores range from 0 to 145, with a mean of 100 and a standard deviation of 15. Higher scores reflect better performance. Scores of zero are valid, indicating performance 6.65 SD below average. The test includes a validity check (p \< .01) for random responses, allowing scores to be set to zero if effort was made. Rating scales are available for additional validity assessment.
Outcome measures
Outcome data not reported
SECONDARY outcome
Timeframe: From enrollment to the end of treatment at 4 weeksThe NeuroSky device will be used to measure alpha brainwave activity, a marker of relaxation and focused attention, as a secondary outcome. Mindfulness-based neurofeedback training will aim to enhance alpha activity by providing participants with real-time feedback on their brainwave patterns. During each session, participants will learn to modulate their alpha levels through mindfulness techniques, fostering a state of calm alertness. Increased alpha activity is associated with improved emotional regulation, reduced stress, and enhanced cognitive functioning. Pre- and post-intervention alpha activity levels will be compared to evaluate the effectiveness of the mindfulness-based neurofeedback training.
Outcome measures
Outcome data not reported
SECONDARY outcome
Timeframe: From enrollment to the end of treatment at 4 weeksThe Mental Stress Assessment (MeSA) will also assess attention by measuring physiological responses during tasks designed to induce and evaluate stress-related attentional shifts.
Outcome measures
Outcome data not reported
SECONDARY outcome
Timeframe: From enrollment to the end of treatment at 4 weeksHeart Rate Variability (HRV) will be measured using the OptimalHRV device. We will examine HRV to determine if participants HRV increased from pre- to post-test which would be an indication of improved autonomic nervous system balance.
Outcome measures
Outcome data not reported
Adverse Events
Mindfulness Neurofeedback
Business as Usual
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place